178 related articles for article (PubMed ID: 38167302)
1. Chronic oxytocin administration stimulates the oxytocinergic system in children with autism.
Moerkerke M; Daniels N; Tibermont L; Tang T; Evenepoel M; Van der Donck S; Debbaut E; Prinsen J; Chubar V; Claes S; Vanaudenaerde B; Willems L; Steyaert J; Boets B; Alaerts K
Nat Commun; 2024 Jan; 15(1):58. PubMed ID: 38167302
[TBL] [Abstract][Full Text] [Related]
2. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
Daniels N; Moerkerke M; Steyaert J; Bamps A; Debbaut E; Prinsen J; Tang T; Van der Donck S; Boets B; Alaerts K
Mol Autism; 2023 Apr; 14(1):16. PubMed ID: 37081454
[TBL] [Abstract][Full Text] [Related]
3. Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up.
Alaerts K; Steyaert J; Vanaudenaerde B; Wenderoth N; Bernaerts S
Eur Neuropsychopharmacol; 2021 Feb; 43():147-152. PubMed ID: 33309460
[TBL] [Abstract][Full Text] [Related]
4. Endogenous oxytocin levels in children with autism: Associations with cortisol levels and oxytocin receptor gene methylation.
Evenepoel M; Moerkerke M; Daniels N; Chubar V; Claes S; Turner J; Vanaudenaerde B; Willems L; Verhaeghe J; Prinsen J; Steyaert J; Boets B; Alaerts K
Transl Psychiatry; 2023 Jun; 13(1):235. PubMed ID: 37391413
[TBL] [Abstract][Full Text] [Related]
5. Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial.
Kosaka H; Okamoto Y; Munesue T; Yamasue H; Inohara K; Fujioka T; Anme T; Orisaka M; Ishitobi M; Jung M; Fujisawa TX; Tanaka S; Arai S; Asano M; Saito DN; Sadato N; Tomoda A; Omori M; Sato M; Okazawa H; Higashida H; Wada Y
Transl Psychiatry; 2016 Aug; 6(8):e872. PubMed ID: 27552585
[TBL] [Abstract][Full Text] [Related]
6. Can repeated intranasal oxytocin administration affect reduced neural sensitivity towards expressive faces in autism? A randomized controlled trial.
Moerkerke M; Daniels N; Van der Donck S; Tibermont L; Tang T; Debbaut E; Bamps A; Prinsen J; Steyaert J; Alaerts K; Boets B
J Child Psychol Psychiatry; 2023 Nov; 64(11):1583-1595. PubMed ID: 37278339
[TBL] [Abstract][Full Text] [Related]
7. At the Head and Heart of Oxytocin's Stress-Regulatory Neural and Cardiac Effects: A Chronic Administration RCT in Children with Autism.
Alaerts K; Daniels N; Moerkerke M; Evenepoel M; Tang T; Van der Donck S; Chubar V; Claes S; Steyaert J; Boets B; Prinsen J
Psychother Psychosom; 2023; 92(5):315-328. PubMed ID: 37820592
[TBL] [Abstract][Full Text] [Related]
8. Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.
Yamasue H; Kojima M; Kuwabara H; Kuroda M; Matsumoto K; Kanai C; Inada N; Owada K; Ochi K; Ono N; Benner S; Wakuda T; Kameno Y; Inoue J; Harada T; Tsuchiya K; Umemura K; Yamauchi A; Ogawa N; Kushima I; Ozaki N; Suyama S; Saito T; Uemura Y; Hamada J; Kano Y; Honda N; Kikuchi S; Seto M; Tomita H; Miyoshi N; Matsumoto M; Kawaguchi Y; Kanai K; Ikeda M; Nakamura I; Isomura S; Hirano Y; Onitsuka T; Kosaka H; Okada T
Brain; 2022 Apr; 145(2):490-499. PubMed ID: 35067719
[TBL] [Abstract][Full Text] [Related]
9. Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up.
Bernaerts S; Boets B; Bosmans G; Steyaert J; Alaerts K
Mol Autism; 2020; 11(1):6. PubMed ID: 31969977
[TBL] [Abstract][Full Text] [Related]
10. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial.
Yatawara CJ; Einfeld SL; Hickie IB; Davenport TA; Guastella AJ
Mol Psychiatry; 2016 Sep; 21(9):1225-31. PubMed ID: 26503762
[TBL] [Abstract][Full Text] [Related]
11. The effect of oxytocin nasal spray on social interaction in young children with autism: a randomized clinical trial.
Guastella AJ; Boulton KA; Whitehouse AJO; Song YJ; Thapa R; Gregory SG; Pokorski I; Granich J; DeMayo MM; Ambarchi Z; Wray J; Thomas EE; Hickie IB
Mol Psychiatry; 2023 Feb; 28(2):834-842. PubMed ID: 36302965
[TBL] [Abstract][Full Text] [Related]
12. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism.
Watanabe T; Kuroda M; Kuwabara H; Aoki Y; Iwashiro N; Tatsunobu N; Takao H; Nippashi Y; Kawakubo Y; Kunimatsu A; Kasai K; Yamasue H
Brain; 2015 Nov; 138(Pt 11):3400-12. PubMed ID: 26336909
[TBL] [Abstract][Full Text] [Related]
13. The role of oxytocin receptor gene (OXTR) DNA methylation (DNAm) in human social and emotional functioning: a systematic narrative review.
Maud C; Ryan J; McIntosh JE; Olsson CA
BMC Psychiatry; 2018 May; 18(1):154. PubMed ID: 29843655
[TBL] [Abstract][Full Text] [Related]
14. Rationale, design, and methods of the Autism Centers of Excellence (ACE) network Study of Oxytocin in Autism to improve Reciprocal Social Behaviors (SOARS-B).
Spanos M; Chandrasekhar T; Kim SJ; Hamer RM; King BH; McDougle CJ; Sanders KB; Gregory SG; Kolevzon A; Veenstra-VanderWeele J; Sikich L
Contemp Clin Trials; 2020 Nov; 98():106103. PubMed ID: 32777383
[TBL] [Abstract][Full Text] [Related]
15. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL
J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908
[TBL] [Abstract][Full Text] [Related]
16. A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research.
DeMayo MM; Song YJC; Hickie IB; Guastella AJ
Paediatr Drugs; 2017 Oct; 19(5):391-410. PubMed ID: 28721467
[TBL] [Abstract][Full Text] [Related]
17. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder.
Sikich L; Kolevzon A; King BH; McDougle CJ; Sanders KB; Kim SJ; Spanos M; Chandrasekhar T; Trelles MDP; Rockhill CM; Palumbo ML; Witters Cundiff A; Montgomery A; Siper P; Minjarez M; Nowinski LA; Marler S; Shuffrey LC; Alderman C; Weissman J; Zappone B; Mullett JE; Crosson H; Hong N; Siecinski SK; Giamberardino SN; Luo S; She L; Bhapkar M; Dean R; Scheer A; Johnson JL; Gregory SG; Veenstra-VanderWeele J
N Engl J Med; 2021 Oct; 385(16):1462-1473. PubMed ID: 34644471
[TBL] [Abstract][Full Text] [Related]
18. Amygdala-Hippocampal Connectivity Is Associated With Endogenous Levels of Oxytocin and Can Be Altered by Exogenously Administered Oxytocin in Adults With Autism.
Alaerts K; Bernaerts S; Vanaudenaerde B; Daniels N; Wenderoth N
Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jul; 4(7):655-663. PubMed ID: 30846366
[TBL] [Abstract][Full Text] [Related]
19. Chronic oxytocin improves neural decoupling at rest in children with autism: an exploratory RCT.
Alaerts K; Moerkerke M; Daniels N; Zhang Q; Grazia R; Steyaert J; Prinsen J; Boets B
J Child Psychol Psychiatry; 2024 Feb; ():. PubMed ID: 38400592
[TBL] [Abstract][Full Text] [Related]
20. The altered promoter methylation of oxytocin receptor gene in autism.
Elagoz Yuksel M; Yuceturk B; Karatas OF; Ozen M; Dogangun B
J Neurogenet; 2016; 30(3-4):280-284. PubMed ID: 27309964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
